We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PKX icon
9876
PUT
POSCO
PKX
$17.7B
$276K ﹤0.01%
6,200
-7,600
-55% -$419K
TNYA icon
9877
Tenaya Therapeutics
TNYA
$163M
$276K ﹤0.01%
+48,960
New +$396K
TYO icon
9878
CALL
Direxion Daily 7-10 Year Treasury Bear 3X ETF
TYO
$11.7M
$276K ﹤0.01%
+24,100
New +$277K
VYGR icon
9879
CALL
Voyager Therapeutics
VYGR
$201M
$276K ﹤0.01%
46,700
-46,000
-50% -$311K
ZUMZ icon
9880
PUT
Zumiez
ZUMZ
$314M
$276K ﹤0.01%
10,600
-1,800
-15% -$60.6K
ALBO
9881
PUT
DELISTED
Albireo Pharma Inc
ALBO
$276K ﹤0.01%
13,900
+7,000
+101% +$185K
DOLE icon
9882
PUT
Dole
DOLE
$1.26B
$275K ﹤0.01%
32,500
-56,900
-64% -$625K
FULC icon
9883
Fulcrum Therapeutics
FULC
$285M
$275K ﹤0.01%
56,047
-56,156
-50% -$549K
HYFM icon
9884
CALL
Hydrofarm Holdings
HYFM
$7M
$275K ﹤0.01%
7,910
+1,150
+17% +$93.6K
NWPX icon
9885
PUT
NWPX Infrastructure Inc
NWPX
$1.12B
$275K ﹤0.01%
+9,200
New +$273K
ROOT icon
9886
Root
ROOT
$797M
$275K ﹤0.01%
12,852
+162
+1% +$4.39K
SKM icon
9887
CALL
SK Telecom
SKM
$14.8B
$275K ﹤0.01%
12,300
+2,280
+23% +$57.5K
TDTT icon
9888
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
$2.53B
$275K ﹤0.01%
11,088
-3,561
-24% -$90.3K
NATI
9889
PUT
DELISTED
National Instruments Corp
NATI
$275K ﹤0.01%
+8,800
New +$312K
IUSA
9890
DELISTED
Amberwave Invest USA JSG Fund
IUSA
$275K ﹤0.01%
18,019
+6,342
+54% +$104K
ARGUW
9891
DELISTED
Argus Capital Corp. Warrant
ARGUW
$275K ﹤0.01%
1,374,288
+11,788
+0.9% +$3.49K
AVA icon
9892
Avista
AVA
$3.28B
$274K ﹤0.01%
6,294
-16,532
-72% -$711K
EHC icon
9893
Encompass Health
EHC
$12.2B
$274K ﹤0.01%
6,130
-86,507
-93% -$4.44M
IXC icon
9894
PUT
iShares Global Energy ETF
IXC
$2.77B
$274K ﹤0.01%
8,100
+2,200
+37% +$82.4K
MMI icon
9895
PUT
Marcus & Millichap
MMI
$1.2B
$274K ﹤0.01%
+7,400
New +$322K
HYZN
9896
CALL
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$274K ﹤0.01%
1,866
-3,474
-65% -$736K
IPOF
9897
CALL
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
$274K ﹤0.01%
27,600
-88,700
-76% -$899K
ANY icon
9898
CALL
Sphere 3D
ANY
$18.1M
$273K ﹤0.01%
7,266
-2,340
-24% -$202K
BRT
9899
PUT
BRT Apartments
BRT
$270M
$273K ﹤0.01%
+12,700
New +$280K
COLD icon
9900
PUT
Americold
COLD
$4.25B
$273K ﹤0.01%
9,100
-3,500
-28% -$97.3K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.